Journal of Targeted Oncology Research

Frequency : Bi-Annual (Two issues per year)
Editorial & Review Timeline
3 - 6 Days Initial Quality Review
30 Days Peer Evaluation Summary
45 - 60 Days Complete Editorial Processing Time

Immuno-Oncology

Immuno-oncology explores the use of the immune system to prevent, control, and treat cancer. Research in this field includes immune checkpoint inhibitors, cancer vaccines, monoclonal antibodies, and cellular immunotherapies. Advances in immuno-oncology continue to improve therapeutic options and contribute to the development of innovative cancer treatment approaches.